NVIDIA Corporation (NASDAQ:NVDA) is one of the high growth stocks to buy right now. On June 23, NVIDIA introduced the BioNeMo ...

NVIDIA (NasdaqGS:NVDA) has launched its BioNeMo Agent Toolkit, aimed at AI driven workflows in biology, chemistry, genomics, ...

The suite of tools is designed to allow AI to carry out R&D work more quickly, reliably, and in a continuous innovation loop.

Nvidia expands BioNeMo, Vera Rubin, and Halos platforms as Jamendo lawsuit raises fresh questions around AI training data.

Industry and research leaders including Dassault Systèmes, Databricks, Lilly, OpenAI, Schrödinger, Snowflake, the UW Medicine Institute for Protein Design and dozens others are adopting, and Anthropic ...

Artificial intelligence played a prominent role at this week’s Bio International Convention in San Diego, the largest biotech ...

Tecan, a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities ...

SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- J.P. Morgan Healthcare Conference-- NVIDIA today announced a major expansion of NVIDIA BioNeMo™, an open development platform that enables ...

Artificial, a provider of cloud-based solutions for streamlining life science laboratories’ operations, has shared the results of a proof-of-concept designed to showcase the integration of its ...

ATLANTA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- SC24-- NVIDIA today announced that global pharmaceutical and techbio industry leaders, academic pioneers and AI researchers are adopting the open-source ...

Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) on Tuesday announced BioNeMo Agent Toolkit, a suite of software tools designed to help ...

Nvidia (NVDA) announced that global pharmaceutical and techbio industry leaders, academic pioneers and AI researchers are adopting the open-source NVIDIA BioNeMo Framework to advance drug discovery ...